Eye health hero to be honoured at IAPB

Article

Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.

Dr Albrecht Hennig, inventor of the 'Fish Hook Technique' for cataract surgery, will be one of the 'Eye Health Heroes' honoured at the International Agency for the Prevention of Blindness (IAPB) 2012 9th General Assembly.

The event, to be held in Hyderbad, India from 17–20 September, will play host to a plethora of eyecare professionals including Dr Hennig who runs the Sagarmantha Choudhary Eye Hospital (SCEH), Lahan, Nepal.

Dr Hennig has heavily contributed towards reducing blindness in Nepal with a 79% decrease in the Sagarmatha Zone and a 65% decrease in the Koshi Zone. The SCEH was primarily a 12-bed hospital, but today it has blossomed into a network of two high-volume hospitals and eight eye care centres.

Dr Hennig has completed over 115,000 cataract surgeries on both adults and children. He said, "Seeing this positive change in children and knowing that with their improved vision they will have better chances in life is my biggest reward."

In addition to this, there will be a large scientific program featuring 40 courses, keynote lectures and symposia, as well as a trade exhibition.

To register your place at the IAPB and take advantage of a special discount please visit www.9ga.iapb.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.